OpenURL Connection Search

Select item for more details and to access through your institution.

Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1.
Published in:
2007
By:
- Sosenko JM;
- Palmer JP;
- Greenbaum CJ;
- Mahon J;
- Cowie C;
- Krischer JP;
- Chase HP;
- White NH;
- Buckingham B;
- Herold KC;
- Cuthbertson D;
- Skyler JS;
- Sosenko, Jay M;
- Palmer, Jerry P;
- Greenbaum, Carla J;
- Mahon, Jeffrey;
- Cowie, Catherine;
- Krischer, Jeffrey P;
- Chase, H Peter;
- White, Neil H
Publication type:
journal article
Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.
Published in:
2006
By:
- Sosenko JM;
- Palmer JP;
- Greenbaum CJ;
- Mahon J;
- Cowie C;
- Krischer JP;
- Chase HP;
- White NH;
- Buckingham B;
- Herold KC;
- Cuthbertson D;
- Skyler JS;
- Sosenko, Jay M;
- Palmer, Jerry P;
- Greenbaum, Carla J;
- Mahon, Jeffrey;
- Cowie, Catherine;
- Krischer, Jeffrey P;
- Chase, H Peter;
- White, Neil H
Publication type:
journal article
Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study.
Published in:
2006
By:
- Seyfert-Margolis V;
- Gisler TD;
- Asare AL;
- Wang RS;
- Dosch HM;
- Brooks-Worrell B;
- Eisenbarth GS;
- Palmer JP;
- Greenbaum CJ;
- Gitelman SE;
- Nepom GT;
- Bluestone JA;
- Herold KC
Publication type:
Journal Article
Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria.
Published in:
2001
By:
- Greenbaum CJ;
- Cuthbertson D;
- Krischer JP;
- Diabetes Prevention Trial of Type 1 Diabetes Study Group;
- Greenbaum, C J;
- Cuthbertson, D;
- Krischer, J P;
- Disease Prevention Trial of Type I Diabetes Study Group
Publication type:
journal article
The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetes.
Published in:
2012
By:
- Sosenko JM;
- Skyler JS;
- Mahon J;
- Krischer JP;
- Beam CA;
- Boulware DC;
- Greenbaum CJ;
- Rafkin LE;
- Cowie C;
- Cuthbertson D;
- Palmer JP;
- Type 1 Diabetes TrialNet Study Group;
- Sosenko, Jay M;
- Skyler, Jay S;
- Mahon, Jeffrey;
- Krischer, Jeffrey P;
- Beam, Craig A;
- Boulware, David C;
- Greenbaum, Carla J;
- Rafkin, Lisa E
Publication type:
journal article
Dead or alive?
Published in:
2012
By:
- Greenbaum CJ;
- Greenbaum, Carla J
Publication type:
Editorial
Failure to preserve beta-cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new- onset type 1 diabetes.
Published in:
2010
By:
- Gottlieb PA;
- Quinlan S;
- Krause-Steinrauf H;
- Greenbaum CJ;
- Wilson DM;
- Rodriguez H;
- Schatz DA;
- Moran AM;
- Lachin JM;
- Skyler JS;
- Type 1 Diabetes TrialNet MMF/DZB Study Group;
- Gottlieb, Peter A;
- Quinlan, Scott;
- Krause-Steinrauf, Heidi;
- Greenbaum, Carla J;
- Wilson, Darrell M;
- Rodriguez, Henry;
- Schatz, Desmond A;
- Moran, Antoinette M;
- Lachin, John M
Publication type:
journal article
Preservation of beta-cell function in autoantibody-positive youth with diabetes.
Published in:
2009
By:
- Greenbaum CJ;
- Anderson AM;
- Dolan LM;
- Mayer-Davis EJ;
- Dabelea D;
- Imperatore G;
- Marcovina S;
- Pihoker C;
- SEARCH Study Group;
- Greenbaum, Carla J;
- Anderson, Andrea M;
- Dolan, Lawrence M;
- Mayer-Davis, Elizabeth J;
- Dabelea, Dana;
- Imperatore, Giuseppina;
- Marcovina, Santica;
- Pihoker, Catherine
Publication type:
journal article
Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes.
Published in:
2008
By:
- Greenbaum CJ;
- Mandrup-Poulsen T;
- McGee PF;
- Battelino T;
- Haastert B;
- Ludvigsson J;
- Pozzilli P;
- Lachin JM;
- Kolb H;
- Greenbaum, Carla J;
- Mandrup-Poulsen, Thomas;
- McGee, Paula Friedenberg;
- Battelino, Tadej;
- Haastert, Burkhard;
- Ludvigsson, Johnny;
- Pozzilli, Paolo;
- Lachin, John M;
- Kolb, Hubert;
- Type 1 Diabetes Trial Net Research Group;
- European C-Peptide Trial Study Group
Publication type:
journal article
Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function.
Published in:
2012
By:
- Long SA;
- Rieck M;
- Sanda S;
- Bollyky JB;
- Samuels PL;
- Goland R;
- Ahmann A;
- Rabinovitch A;
- Aggarwal S;
- Phippard D;
- Turka LA;
- Ehlers MR;
- Bianchine PJ;
- Boyle KD;
- Adah SA;
- Bluestone JA;
- Buckner JH;
- Greenbaum CJ;
- for Diabetes TrialNet and the Immune Tolerance Network;
- Long, S Alice
Publication type:
journal article
Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data.
Published in:
2012
By:
- Greenbaum CJ;
- Beam CA;
- Boulware D;
- Gitelman SE;
- Gottlieb PA;
- Herold KC;
- Lachin JM;
- McGee P;
- Palmer JP;
- Pescovitz MD;
- Krause-Steinrauf H;
- Skyler JS;
- Sosenko JM;
- Type 1 Diabetes TrialNet Study Group;
- Greenbaum, Carla J;
- Beam, Craig A;
- Boulware, David;
- Gitelman, Stephen E;
- Gottlieb, Peter A;
- Herold, Kevan C
Publication type:
journal article
Through the fog: recent clinical trials to preserve β-cell function in type 1 diabetes.
Published in:
2012
By:
- Greenbaum CJ;
- Schatz DA;
- Haller MJ;
- Sanda S;
- Greenbaum, Carla J;
- Schatz, Desmond A;
- Haller, Michael J;
- Sanda, Srinath
Publication type:
journal article
Comment on: Atkinson. It's time to consider changing the rules: the rationale for rethinking control groups in clinical trials aimed at reversing type 1 diabetes. Diabetes 2011;60:361-363.
Published in:
2011
By:
- Sanda S;
- Greenbaum CJ;
- Sanda, Srinath;
- Greenbaum, Carla J
Publication type:
commentary

Found: 13